Related Experiment Videos
Bloodletting for non-medical reasons: what about safety and quality?
O Garraud1,2, J D Tissot3
1Institut National de la Transfusion Sanguine, Paris, France.
Transfusion Medicine (Oxford, England)
|August 25, 2015
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Platelet transfusion in adults: An update.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2022
Transfusion at the border of the "intention-to-treat", in the very aged person and in palliative care: A debate.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021
International collaboration for blood safety: The French-African experience.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Transfusion medicine: Overtime paradigm changes and emerging paradoxes.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Blood, perceptions, resource and ownership: When transfusion illustrates the complexity.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Preoperative intravenous iron and red blood cell transfusion requirements in elderly intertrochanteric femoral fractures.
Transfusion medicine (Oxford, England)·2026
Developing key performance indicators using routinely collected healthcare data in obstetric patient blood management: A multi-stage consensus study.
Transfusion medicine (Oxford, England)·2026
Red blood cell-directed immune responses in COVID-19: Mechanisms, clinical evidence and implications for transfusion medicine.
Transfusion medicine (Oxford, England)·2026
Managing pregnancy in women with the Rh-null phenotype: A structured narrative review of alloimmunisation, maternal-fetal outcomes and transfusion management.
Transfusion medicine (Oxford, England)·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026
From prediction to practice: Barriers to implementing artificial intelligence in blood inventory management and transfusion support.
Transfusion medicine (Oxford, England)·2026
Renal Denervation via Left Transradial Artery Approach to Circumvent Infrarenal Aortic Tortuosity.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Haemorrhagic event reporting with concomitant gemcitabine and warfarin: a VigiBase disproportionality analysis.
Frontiers in pharmacology·2026
Teclistamab in relapsed, multi-refractory acquired hemophilia A after failure of anti-CD19 CAR-T cell therapy.
Journal of thrombosis and haemostasis : JTH·2026